Clinical Trials for Psoriasis Vulgaris

Topical SGX302 for Mild-to-Moderate Psoriasis

NCT ID: NCT05442190

This clinical trial is studying a new treatment called SGX302, which is a topical ointment made with hypericin, used alongside visible light therapy. The aim is to see if this treatment can help im...

The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions

NCT ID: NCT06887322

Prevalence and Risk Factors AsSOciated with CArdiac ComorbiDIty in PsoriAsis

NCT ID: NCT04950218

The Psoriasis Echo Study is a clinical trial that looks at the relationship between heart health and psoriasis, a skin condition that causes red, itchy patches. Researchers want to find out if cert...

Proactive TDM Versus Standard Use of Biologics in Psoriasis

NCT ID: NCT06398106

This clinical trial is looking at how to improve the treatment of psoriasis, specifically a common type known as psoriasis vulgaris. It compares two approaches to dosing biologic medications, which...

Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

NCT ID: NCT04080635

The BIOLOPTIM-BRO clinical trial is studying the medication brodalumab, which is used to treat moderate-to-severe psoriasis, a chronic skin condition. This trial aims to find out how effective meas...

Topical Thymoquinone in Psoriasis Vulgaris

NCT ID: NCT06508372

This clinical trial is looking at the effects of a natural substance called thymoquinone, found in black seed oil, on people with mild psoriasis vulgaris, a common skin condition that causes red, s...

Correction of Psoriatic T Cell Signatures by Deucravacitinib

NCT ID: NCT05858645

**Summary of the Clinical Trial on Deucravacitinib for Psoriasis** This clinical trial is studying a new treatment, called deucravacitinib, for people with moderate to severe psoriasis, a skin con...

Botox Versus Tacrolimus in Psoriasis Vulgaris

NCT ID: NCT06203470

This clinical trial is comparing two treatments for psoriasis vulgaris, a common skin condition that causes red, scaly patches on the skin. The study will look at how effective Botox and Tacrolimus...

PSODEEP2 Pilot Study on Koebner Induction in Psoriasis

NCT ID: NCT06414382

The PSODEEP2 Pilot Study is a research trial looking at a specific reaction in people with psoriasis called the Koebner phenomenon. This happens when new psoriasis patches develop on skin that has ...

Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis

NCT ID: NCT05102474

This clinical trial is studying how sleep affects people with moderate to severe psoriasis, a skin condition that can cause discomfort and other health issues. Researchers want to find out if peopl...

Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis

NCT ID: NCT05815797

This clinical trial is studying a traditional Chinese medicine formula called "Shuiniujiao Dihuang Decoction with Variation" (SDD) to see if it can help treat psoriasis vulgaris, a common skin cond...

Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)

NCT ID: NCT05685940

This clinical trial, called BIOLOPTIM-RIS, is studying how to better monitor the drug risankizumab in patients with psoriasis vulgaris, which is a common form of psoriasis that causes raised, red p...

Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients

NCT ID: NCT05683015

This clinical trial is studying a medication called tildrakizumab, which is used to treat moderate to severe psoriasis, a skin condition that causes red, scaly patches. The researchers want to find...

Psoriatic Immune Response to Tildrakizumab

NCT ID: NCT05390515

This clinical trial is studying how the immune system responds to a treatment called tildrakizumab in patients with moderate to severe psoriasis, a skin condition that causes red, scaly patches on ...

Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation

NCT ID: NCT05243303

This clinical trial is looking at a new way to help people with plaque psoriasis, a condition that causes red, scaly patches on the skin. Researchers want to see if a treatment called transcutaneou...